Sucampo Pharmaceuticals, Inc. Watch

from SC TO-C 108 pages Agreement and Plan of Merger Among: Sucampo Pharmaceuticals, Inc., a Delaware Corporation; Mallinckrodt PLC, an Irish Public Limited Company; and Sun Acquisition Co., a Delaware Corporation Dated as of December 23, 2017

from 8-K 108 pages Agreement and Plan of Merger Among: Sucampo Pharmaceuticals, Inc., a Delaware Corporation; Mallinckrodt PLC, an Irish Public Limited Company; and Sun Acquisition Co., a Delaware Corporation Dated as of December 23, 2017

from 10-Q 187 pages Agreement and Plan of Merger by and Among Sucampo Pharmaceuticals, Inc., Saber Merger Sub, Inc., Vtesse Inc. And, Solely in Its Capacity as Company Equityholder Representative, Fortis Advisors LLC Dated as of March 31, 2017

from 8-K 57 pages Stock Purchase Agreement by and Among Sucampo Pharmaceuticals, Inc., Ambrent Investments S.À R.L., Ryuji Ueno, as Trustee of the Ryuji Ueno Revocable Trust Under Trust Agreement Dated December 20, 2002, Sachiko Kuno, as Trustee of the Sachiko Kuno Revocable Trust Under Trust Agreement Dated December 20, 2002, Dr. Ryuji Ueno, and Dr. Sachiko Kuno Dated as of December 23, 2010

from 8-K 9 pages Agreement and Plan of Reorganization